Protocol No.: CV181147; A Multicenter, Randomized, double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Saxagliptin (BMS-477118) in Combination with Metformin XR in Pediatric patients with Type 2 Diabetes who have Inadequate Gly

Project: Other project

StatusFinished
Effective start/end date8/17/128/16/14

Funding

  • Parexel International: $2,202.47